MedHub-AI Receives PMDA Approval in Japan for AutocathFFR®
TEL AVIV, Israel, June 18, 2025 /PRNewswire/ — MedHub-AI, a global leader in AI-powered cardiovascular diagnostics, announced today that the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has approved AutocathFFR®, the company’s non-invasive, AI-driven… Read More »MedHub-AI Receives PMDA Approval in Japan for AutocathFFR®